News & Events
For media inquiries email [email protected]
Company news
October 28, 2024
Press Release
Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platform
Publications and presentations
March 5, 2024
Nature Communications
Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins
November 20, 2023
Nature Communications
Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides
December 19, 2022
PNAS
De novo mapping of α-helix recognition sites on protein surfaces using unbiased libraries
Recent highlights
November 4, 2024
Virtual
Truist Tru-Talks with Parabilis Medicines
Parabilis CEO Mathai Mammen joined Kripa Devarakonda at Truist for a discussion about our Helicon discovery platform, our pipeline of investigational medicines, and our ongoing clinical trial of FOG-001. Click to view the recorded webcast. (Registration required; list Kripa Devarakonda as Truist representative.)
Upcoming events
January 14, 2025
San Francisco, CA